No Data
No Data
huapont life sciences (002004.SZ): has cumulatively repurchased 6.9599 million shares
On September 2, Guolonghui reported that huapont life sciences (002004.SZ) announced that as of August 31, 2024, the company has repurchased a total of 6.959908 million shares of the company through centralized trading, accounting for 0.35% of the company's current total share capital. The highest fill price was 4.65 yuan/share, the lowest fill price was 3.84 yuan/share, and the total amount paid was 29.4993 million yuan (excluding trading fees).
Huabang Health: 2024 Semi-Annual Report Summary
Huabang Health: 2024 Semi-Annual Report
huapont life sciences (002004.SZ): the net income in the first half of the year was 0.314 billion yuan, a decrease of 19.02% year-on-year.
Huapont Life Sciences (002004.SZ) announced its semi-annual report for the year 2024, with total revenue of 5.922 billion yuan, a year-on-year increase of 0.91%; net income attributable to shareholders of the listed company was 0.314 billion yuan, a year-on-year decrease of 19.02%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.296 billion yuan, a year-on-year decrease of 21.64%; basic earnings per share was 0.1586 yuan.
Huapont Life Sciences (002004.SZ) released its performance for the first half of the year, with a net income of 0.314 billion yuan, a decrease of 19.02%.
Huapont Life Sciences (002004.SZ) released its 2024 interim report, during the reporting period, the company achieved revenue...
Huapont Life Sciences (002004.SZ): As of August 9, 2024, the company has 79,239 shareholders.
On August 13th, Gelonhui reported that as of August 9th, 2024, the number of shareholders of Huapont Life Sciences (002004.SZ) was 79,239.
No Data
No Data